Iluvien

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
0246820082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE To describe the anterior chamber migration of a fluocinolone acetonide (Iluvien) implant in the context of previous… (More)
Is this relevant?
2017
2017
INTRODUCTION It is hypothesized that using fluocinolone acetonide (FAc) implants such as Iluvien for the treatment of diabetic… (More)
Is this relevant?
Review
2017
Review
2017
The first-line therapy for patients with center-involving diabetic macular edema (DME) is with intravitreal anti-vascular… (More)
Is this relevant?
2016
2016
IMPORTANCE A case showing sustained structural and functional responses 2 years after a single treatment with ILUVIEN (0.2 µg/day… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2016
2016
INTRODUCTION We describe a proactive method using electronic patient records (EPR) to identify pseudophakic patients with… (More)
  • figure 1
  • table 3
Is this relevant?
2015
2015
PURPOSE The purpose of this study was to evaluate the systemic and ocular pharmacokinetics (PK) of fluocinolone acetonide (FAc… (More)
Is this relevant?
2015
2015
INTRODUCTION Fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN(®); Alimera Sciences Limited, Aldershot, UK) has been… (More)
Is this relevant?
Review
2015
Review
2015
Diabetic macular edema (DME) is a frequent complication of diabetic retinopathy and may cause severe visual loss. In this article… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2015
2015
I read ''Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis (NIPU): 3… (More)
Is this relevant?
Review
2008
Review
2008
Iluvien (fluocinolone acetonide intravitreal insert, Alimera Sciences, Inc.), a novel injectable intravitreal insert, is being… (More)
Is this relevant?